Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines.
Views & Analysis How artificial intelligence is empowering healthcare It is hard to think of any area of our lives that might not one day be affected by artificial intelligence, and an exponential rise in recent years has already seen it become increasingly e
Partner Content Partner Content 3rd Annual AI-ML Drug Discovery & Development Summit Discover Case Studies of Machine Learning in Action
Views & Analysis The steps for successful AI We speak to machine learning expert Loubna Bouarfa about getting life sciences to embrace AI and what makes for a successful use of the technology.
Views & Analysis Harnessing the potential of AI in commercial life sciences Artificial intelligence (AI) has gained significant momentum in life sciences over the past few years.
News Genentech buys Regor's next-gen CDK inhibitors for $850M Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors to Roche's Genentech for an upfront cash payment of $850 million.
R&D Sponsored Beyond clinical: Boosting recruitment and retention with SDO... The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.